Triglav Skladi D.O.O. Invests $380,000 in Agilent Technologies, Inc. (NYSE:A)

Triglav Skladi D.O.O. bought a new stake in Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,830 shares of the medical research company’s stock, valued at approximately $380,000.

A number of other large investors have also recently made changes to their positions in the company. Flynn Zito Capital Management LLC boosted its position in shares of Agilent Technologies by 3.8% in the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after purchasing an additional 69 shares during the period. IFP Advisors Inc boosted its position in shares of Agilent Technologies by 17.7% in the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after purchasing an additional 69 shares during the period. Tiemann Investment Advisors LLC boosted its position in shares of Agilent Technologies by 5.6% in the 4th quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock valued at $191,000 after purchasing an additional 75 shares during the period. Rothschild Investment LLC raised its stake in Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock valued at $66,000 after acquiring an additional 79 shares during the last quarter. Finally, CIBC Private Wealth Group LLC raised its stake in Agilent Technologies by 1.2% during the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company’s stock valued at $1,025,000 after acquiring an additional 87 shares during the last quarter.

Insider Activity at Agilent Technologies

In other news, Director Daniel K. Podolsky sold 1,819 shares of the business’s stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the transaction, the director now directly owns 35,737 shares of the company’s stock, valued at $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. This trade represents a 8.05% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Wall Street Analyst Weigh In

Several analysts have commented on A shares. Jefferies Financial Group reduced their price objective on Agilent Technologies from $135.00 to $116.00 and set a “hold” rating for the company in a research note on Monday, April 21st. TD Cowen upped their price objective on Agilent Technologies to $135.00 and gave the company a “buy” rating in a research note on Thursday, April 10th. Barclays reduced their price objective on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research note on Thursday, April 10th. Robert W. Baird reduced their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. Finally, Wells Fargo & Company reduced their price objective on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating for the company in a research note on Thursday, April 17th. Seven analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $143.00.

Agilent Technologies Stock Performance

Shares of A stock opened at $113.76 on Monday. The company has a market cap of $32.43 billion, a price-to-earnings ratio of 26.15, a price-to-earnings-growth ratio of 3.21 and a beta of 1.27. The stock has a 50 day simple moving average of $110.44 and a 200-day simple moving average of $128.16. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $154.95. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. On average, equities analysts forecast that Agilent Technologies, Inc. will post 5.54 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st were paid a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.87%. The ex-dividend date was Tuesday, April 1st. Agilent Technologies’s payout ratio is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.